This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To the Editor

Measuring Efficacy of Polypharmacy in Schizophrenic Inpatients

Jean-Pierre Lindenmayer, MD

Published: August 16, 2004

Article Abstract

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: McCue et al.1 compare a number of indirect parameters assessing the effectiveness of polypharmacy in the treatment of acutely ill inpatients with schizophrenia. While we all welcome data that would support the safety and rationality of polypharmacy in schizophrenia treatment, the data the authors present are difficult to interpret. Their study carries some methodological flaws and uses a number of indirect parameters that most likely have alternative explanations.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 65

Quick Links: Schizophrenia and Schizoaffective Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Original Research

Prevalence and Correlates of Obsessive-Compulsive Symptoms in Individuals With Schizophrenia, Schizoaffective Disorder, or Bipolar Disorder

Prevalence and correlates of obsessive-compulsive symptoms and OCD were identified from the case records of over 22,500...

Read More...